MAGEA3 and cancer: Adenosine monophosphate-activated protein kinase was recently shown to be degraded by the cancer-specific MAGE-A3/6-TRIM28 ubiquitinase in cancer cells leading to its downregulation and hypersensitivity to AMPK agonists AICAR and metformin (Pineda et al, 2015).